Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Böhler, T.
Right arrow Articles by Schärer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Böhler, T.
Right arrow Articles by Schärer, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1993) 8: 140-145
© 1993 European Renal Association-European Dialysis and Transplant Association

research-article

Haemorheological changes in uraemic children in response to erythropoietin treatment

T. Böhler1,, A. Leo1, O. Linderkamp1, A. Braun2 and K. Schärer2

1Division of Neonatology, University of Heidelberg Germany 2Division of Pediatric Nephrology, Department of Pediatrics, University of Heidelberg Germany

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr Thomas Böhler, Univers-itats-Kinderklinik, Im Neuenheimer Feld 150, D-6900 Heidelberg, Germany

The increased risk of hypertension during treatment of uraemic patients with recombinant human erythropoietin (rHuEpo) has been related to increased blood viscosity. We therefore studied Theological parameters determining whole blood viscosity in seven haemodialysed uraemic children and adolescents during treatment with rHuEpo (initial dose 75 IU/kg per week). Before treatment the patients were anaemic and had reduced red blood cell (RBC) deformability at low shear stress of 0.7 Pa in the rheoscope compared with six healthy control children (0.14 ±0.03 versus 0.19±0.02). The RBC membrane rigidity (i.e. membrane elastic shear modulus) determined in a flow channel was increased (2.04 ±0.26 versus 1.36±0.05 x 10–5 N/m). After two weeks of rHuEpo, RBC deformability improved and RBC membrane rigidity decreased significantly. With increasing doses of rHuEpo the haematocrit rose steadily. After 14 weeks of therapy RBC deformability reached control values, and after 30 weeks RBC membrane rigidity became normal. RBC aggregation and plasma viscosity were similar in patients and controls and did not change significantly in response to rHuEpo. The early improvement of RBC deformability may lead to an increase in tissue oxygenation by facilitating microcir-culatory blood flow.

Keywords: erythropoietin; renal anaemia; erythrocyte deformability; erythrocyte aggregation; plasma viscosity; children


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
M Piagnerelli, K Zouaoui Boudjeltia, D Brohee, A Vereerstraeten, P Piro, J-L Vincent, and M Vanhaeverbeek
Assessment of erythrocyte shape by flow cytometry techniques
J. Clin. Pathol., May 1, 2007; 60(5): 549 - 554.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
O. Linderkamp
Blood Viscosity of the Neonate
NeoReviews, October 1, 2004; 5(10): e406 - e416.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.